The sequential occurrence of the Pten-deficient malignancies was about 11 weeks for the lymphomas and the endometrial cancer, about 19 weeks for the prostate cancer and squamous cell carcinoma and about 30 weeks for the intestinal cancer (Figure 3D). This evidence concerns the gene PTEN and lymphoma.